NioLeads 
Ray Therapeutics, Inc.
Biotechnology Research · San Francisco, California, United States · 22 Employees
Who is Ray Therapeutics, Inc.
Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Our studies have shown for the first time that our proprietary ChRown optogenetic protein can restore high levels of visual acuity, contrast sensitivity and visual field.
RayTx lead asset, RTx-015, is expected to address the huge unmet medical in people suffering from many forms of retinal blindness (independent of the underlying genetic cause), including those with advanced age-related macular degeneration. RayTx has partnered with a world-leading AAV gene therapy manufacturer is utilizing their proprietary commercial manufacturing process and analytics to maximally de-risk clinical development. RayTx anticipates clinical trials will begin by the end of 2023 in our initial indication, retinitis pigmentosa.
Company Information
Website
Industry
Employees
22
Address
Frequently Asked Questions regarding Ray Therapeutics, Inc.
Where is Ray Therapeutics, Inc. based?
Ray Therapeutics, Inc. is based in San Francisco, California, United States.
What industry does Ray Therapeutics, Inc. belong to?
Ray Therapeutics, Inc. is in the industry of: Biotechnology Research
How many employees does Ray Therapeutics, Inc. have?
22 peoples are employed at Ray Therapeutics, Inc.
What is Ray Therapeutics, Inc.'s official website?
Ray Therapeutics, Inc. official website is
http://www.raytherapeutics.com
What are Ray Therapeutics, Inc. social media links?
Ray Therapeutics, Inc.
LinkedIn
page